Dr. John Cush RheumNow
2 years 7 months ago
#RNL2024 Preview! Our Spondyloarthitis Spectrum pod features Drs. Eric Ruderman, Lihi Eder and Lianne Gensler.
There's still time to register: https://t.co/Qc7rdBfDV0 https://t.co/2tYfxkQfdO
Dr. John Cush RheumNow
2 years 7 months ago
#RNL2024 Speaker Preview!
Be sure to check out our Vasculitis Mavens this weekend! Drs. Catherine Sims, Anisha Dua, and Philip Seo will be leading exciting talks.
https://t.co/inDKp0JsFu https://t.co/L32LqWrvUM
The trouble with rheumatology may be the words we live by. Welcome to the eulogy for rheumatology 'dead words'. We're here today to celebrate the loss of rheumatology past. These are dead words in rheumatology, words fortified unfortunately by history and habit. The lexicon of rheumatology is unique, it's challenging and it's mostly incomprehensible to those who don't know...but those are the cornerstones of the greatest of medical
Dr. John Cush RheumNow
2 years 7 months ago
QD Clinics - Sponsored By https://t.co/4UQlqwujiR
Check out our recent QD clinics in one spot!
https://t.co/WcPt6bzEXM https://t.co/EIWuKq4CjN
Dr. John Cush RheumNow
2 years 7 months ago
Best Treatments for COVID-Related MIS-C
https://t.co/6Ntdug1eam https://t.co/x6de0DQTZ9
Dr. John Cush RheumNow
2 years 7 months ago
Norweigian nationwide study shows males with inflamm Jt. Dz (IJD) have more children and are less likely to be childless compared with matched controls. Males w/ IJD may be reassured that no impairment of fertility is expected https://t.co/PPv8vnkd0m https://t.co/ZepV4ZEfVn
A prospective cohort study suggests the presence of antidrug antibodies may be associated with bDMARDs nonresponse in rheumatoid arthritis (RA). Should we be monitoring ADAbs (especially in nonresponders)?
Dr. John Cush RheumNow
2 years 7 months ago
16% of patients with nr-axSpA progressed to r-axSpA within 5 years. Male sex, fulfillment of the imaging arm of the ASAS criteria, and good response to nonsteroidal anti-inflammatory drugs were predictors of radiographic progression https://t.co/eargDLHUZ2 https://t.co/xG52uMmYK8
Dr. John Cush RheumNow
2 years 7 months ago
Study of 235 newly Dx #RA patients (157 females) found that 11 pts (5%) had carpal tunnel syndrom (CTS) at the time of initial RA diagnosis. Such pts were more likey to be older, female, CCP negative and have a longer Sx duration. https://t.co/0CfF0lKBgk https://t.co/tx9CvQ4TWX
A prospective study of the BioSTAR registry estimates the prevalence of cardiovascular disease in rheumatoid arthritis (RA) to be 4.6%.
Dr. John Cush RheumNow
2 years 7 months ago
No evidence of harm starting urate lowering Tx (ULT) during #gout attack. Metanalysis 6 RCTs (445 pts) w/ gout attacks given ULT vs PBO or delayed ULT. No differences in pain, time to resolve gout flare or risk of recurrent gout flare in 30d (RR 1.06) https://t.co/xUX2U6MmGP https://t.co/2bV0g2FOSK
Dr. John Cush RheumNow
2 years 7 months ago
Meta-analysis of 35 RCTs (>20K pts) with inflammatory skin disorders shows that w/ short-term (<5 mos) use JAK inhibitors do not significantly increase risk of all-cause mortality (OR, 0.83; 0.44-1.57), MACE, or VTE (OR, 0.52; 0.26-1.04). https://t.co/zBlcZ02QqQ https://t.co/cXjswVS9lF
The RECOVERY trial focused on pediatric MIS-C patients treated with immunomodulators and anti-cytokine therapy demonstrated the benefits of first-line therapy with intravenous methylprednisolone or second-line tocilizumab in children refractory to initial treatment. Neither IV immunoglobulin nor anakinra benefitted the duration of hospital stay.
Dr. John Cush RheumNow
2 years 7 months ago
Microbiome study of 16 SLE pts (44 fecal samples) shows that blooms of Ruminococcus gnavus pathobiont was assoc w/ lupus flares and may be the drivers of clinical of relapsing lupus disease https://t.co/OXA4L6kG4p https://t.co/zXX7ZfWik1
